Morgan Petronelli

Adam Friedman, MD, FAAD, outlined his five rules to ensure an effective atopic dermatitis management plan and discussed the current treatments available.

Angelo Landriscina, MD, discusses the recent rise in influence that TikTok has had over the dermatology industry.

A proprietary food supplement designed to balance the gut microbiome and target the over production of skin cells will be examined in an upcoming consumer study that has recently announced participant enrollment.

Soliton announced the FDA has cleared its Rapid Acoustic Pulse (RAP) device for short-term improvement in appearance of cellulite.

This week’s edition of The Mainstream Patient features stories on sunscreen expiration, the link between dairy and acne, the skin barrier, how to manage retinization, plus more.

In case you missed it, some of this week’s featured content includes a new podcast episode, a video series on the COVID-19 vaccine and dermal fillers, topical PRP, expansion of the CoolSculpting portfolio, combination therapies as the future of rosacea treatment, plus more.

In the final part of our interview with Whitney Bowe, MD, she reveals her tips and tricks for both preventing and minimizing any adverse reactions in her filler patients who might have also received the COVID-19 vaccine.

Candela announces the launch of its Frax Pro system, featuring dual-depth skin resurfacing with both novel Frax 1940 and Frax 1550 applicators.

In part 4 of our interview with Whitney Bowe, MD, she dives into the multiple methods physicians can use to treat adverse reactions from the COVID-19 vaccine in their dermal filler patients.

Recent reports have been surfacing in regard to adverse reactions in dermal fillers patients who have also received the COVID-19 vaccine. Whitney Bowe, MD, New York City, New York, discusses this phenomenon and provides some tips for preventing and treating these side effects.

Allergan Aesthetics plans on expanding its CoolSculpting portfolio with the launch of its novel CoolSculpting Elite device that targets visible fat in nine different areas of the body.

In part 3, Whitney Bowe, MD, suggests how physicians should manage their patients' expectations when it comes to HA fillers and the COVID-19 vaccine.

Galderma announced the launch of its Face for Change program that allows abobotulinumtoxinA (Dysport) patients to give back with each treatment received to either Dress for Success or The Skin Cancer Foundation.

In the second part of our interview with Whitney Bowe, MD, she reveals the type of fillers that have been linked to adverse reactions in dermal filler patients who have received the COVID-19 vaccine.

In this expert interview, Whitney Bowe, MD, explains the rare adverse reactions the medical community has recently been seeing in dermal filler patients who received the COVID-19 vaccine.

This week’s edition of The Mainstream Patient features stories on skin icing, TikTok skinfluencers and their impact on the beauty industry, skin picking, blister care, plus more.

ICYMI, some of the content featured this week includes stories on rosacea pathogens, IL-17 and IL-23 inhibitors for psoriasis, navigating practice challenges during a pandemic, and more.

New guidance statements related to COVID-19 vaccines and psoriatic disease patients have been published by the National Psoriasis Foundation (NPF) COVID-19 Task Force.

George Martin, MD, program director of the 2021 Maui Derm Live and Maui Derm Connect annual conferences being held January 25-29 in Maui, Hawaii, shares his checklist of essential advice for optimizing practice management during the COVID-19 pandemic.

Arcutis Biotherapeutics announces the commencement of two identical phase 3 clinical trials evaluating topical PDE4 inhibitor roflumilast cream in patients with mild-to-moderate atopic dermatitis.

This week’s edition of The Mainstream Patient features stories on the benefits of lactic acid, itchy skin during the winter, tretinoin, 2021’s biggest beauty trend, plus more.

ICYMI, some of the content featured this week includes a new podcast episode and stories on finasteride, telehealth, medical device company acquisitions, updates in acne research, plus more.

Esther Freeman, MD, PhD, details how her and her fellow colleagues banded together to create a COVID-19 dermatology registry in just eight days. The registry has since seen over 1,000 submissions from frontline clinicians located in 40 countries, helping to identify and diagnose active COVID-19 through submitted skin findings.

Allergan Aesthetics has entered into a warrant agreement that will give the company an option to acquire Cypris Medical following the completion of a clinical trial evaluating Cypris’ Xact device.

Topicals and oral antibiotics, as well as research on the skin microbiome, are paving the way for the future of acne treatment, according to a recent presentation at the 2020 ODAC Pre-Conference Inflammatory Diseases Symposium.

This week’s edition of The Mainstream Patient features stories on acne treatment alternatives, dermal fillers, skincare regimens for psoriasis, wet hair care, laser treatments, plus more.

ICYMI, some of the content featured this week includes new study results on DAXI, expanding systemic therapies for psoriasis, COVID-19 induced skin challenges, plus more.

A new guidance from the American Society for Dermatologic Surgery (ASDS) has been released regarding side effects from the SARS-CoV-2 mRNA vaccine on dermal fillers.

Revance Therapeutics announces positive results from its phase 2 multicenter, open-label study investigating DaxibotulinumtoxinA (DAXI) as an injectable treatment for glabellar lines, lateral canthal lines and dynamic forehead lines

This week’s edition of The Mainstream Patient features stories on milia, alcohol in skincare, body acne, silicone sheet masks, plus more.